PIR1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of PIR1 Antibodies for research applications. Monoclonal PIR1 Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PIR1, or Programmed Cell Death 1 Receptor, plays a critical role in regulating immune responses and maintaining self-tolerance by inhibiting T-cell activation. PIR1 has emerged as a significant target in cancer immunotherapy and autoimmune disease research. Understanding PIR1 function can provide insights into therapeutic strategies aimed at modulating immune responses. Researchers worldwide rely on PIR1 monoclonal antibodies to advance their studies in immunology and oncology. The high specificity of PIR1 monoclonal antibodies enables precise detection and analysis of immune system mechanisms. Santa Cruz Biotechnology monoclonal antibodies for PIR1 continue to support breakthrough discoveries in immunology research and therapeutic development.